November 2, 2023
PharmaZac sponsors the medical book “Epilepsy and Movement Disorders” of Dr. A. Alexoudi Neurologist Ph.D of National and Kapodistrian University of Athens and Dr. S. Gatzonis, […]
November 2, 2023
Pharmazac launched the new product Cinacalcet 30-60 and 90mg in F.C.Tablets. Cinacalcet indicated for the treatment of secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney […]
November 2, 2023
We are welcoming KRKA in Greece and we are supporting them as their distributor! Pharmazac iw happy to announce that it will begin in December ΄20 […]
November 2, 2023
We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of […]
November 2, 2023
With Covid-19 on the way of most of our exhibiting activities, Pharmazac has joined in 2020 the largest pharmaceutical partnering events and has participated in more […]
November 2, 2023
Pharmazac launched the new product Zaolin/Vinorelbin the first generic version for oral use ( soft gelatin caps) in Greece. Zaolin/Vinorelbin is a chemotherapy drug used to […]
November 2, 2023
Pharmazac is working on its latest investment a new site of 10.000 sq.m for pharmaceuticals manufacturing, in the industrial zone of Keratea near Athens area . […]
November 2, 2023
Pharmazac launched Etrozac / etoricoxib a selective cyclo-oxygenase – 2 (COX-2) inhibitor. Etrozac indicated for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain and […]
November 2, 2023
Pharmazac S.A participates in the online CPhI festival of pharma 2020